Raymond James & Associates’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$298M Buy
860,050
+257,711
+43% +$88.7M 0.18% 99
2024
Q2
$199M Buy
602,339
+18,733
+3% +$6.46M 0.13% 135
2024
Q1
$212M Buy
583,606
+24,708
+4% +$8.13M 0.14% 124
2023
Q4
$167M Sell
558,898
-6,242
-1% -$1.82M 0.13% 146
2023
Q3
$162M Buy
565,140
+126,604
+29% +$36.1M 0.14% 138
2023
Q2
$123M Buy
438,536
+70,775
+19% +$18.4M 0.1% 181
2023
Q1
$94M Sell
367,761
-66,930
-15% -$19.5M 0.08% 222
2022
Q4
$144M Buy
434,691
+14,418
+3% +$4.56M 0.13% 147
2022
Q3
$117M Sell
420,273
-23,992
-5% -$6.75M 0.12% 161
2022
Q2
$117M Buy
444,265
+51,075
+13% +$13.2M 0.11% 168
2022
Q1
$94.2M Buy
393,190
+33,117
+9% +$7.75M 0.08% 218
2021
Q4
$82.7M Buy
360,073
+24,924
+7% +$5.3M 0.07% 252
2021
Q3
$67.1M Buy
335,149
+67,255
+25% +$14.6M 0.06% 273
2021
Q2
$63.5M Buy
267,894
+31,238
+13% +$7.8M 0.06% 283
2021
Q1
$57.2M Sell
236,656
-24,786
-9% -$5.52M 0.06% 281
2020
Q4
$54.4M Buy
261,442
+26,807
+11% +$5.26M 0.06% 270
2020
Q3
$39.8M Buy
234,635
+6,347
+3% +$1.12M 0.05% 309
2020
Q2
$42.8M Buy
228,288
+8,836
+4% +$1.68M 0.06% 277
2020
Q1
$38.9M Sell
219,452
-520
-0.2% -$101K 0.06% 255
2019
Q4
$45M Sell
219,972
-17,491
-7% -$3.21M 0.06% 295
2019
Q3
$36M Sell
237,463
-3,177
-1% -$517K 0.05% 338
2019
Q2
$37.9M Buy
240,640
+4,584
+2% +$718K 0.05% 325
2019
Q1
$38M Sell
236,056
-29,654
-11% -$5.42M 0.06% 318
2018
Q4
$50.5M Buy
265,710
+133,472
+101% +$27.8M 0.09% 213
2018
Q3
$27.5M Sell
132,238
-1,641
-1% -$304K 0.04% 413
2018
Q2
$22.8M Buy
133,879
+2,916
+2% +$505K 0.04% 453
2018
Q1
$22M Sell
130,963
-2,230
-2% -$433K 0.04% 434
2017
Q4
$27.1M Sell
133,193
-5,367
-4% -$1.07M 0.05% 366
2017
Q3
$25.9M Buy
138,560
+12,910
+10% +$2.3M 0.05% 356
2017
Q2
$21M Buy
125,650
+26,528
+27% +$4.26M 0.05% 406
2017
Q1
$14.5M Buy
99,122
+4,374
+5% +$645K 0.03% 518
2016
Q4
$12.6M Sell
94,748
-1,469
-2% -$192K 0.03% 534
2016
Q3
$12.5M Sell
96,217
-4,828
-5% -$630K 0.03% 508
2016
Q2
$12.9M Buy
101,045
+14,048
+16% +$1.85M 0.04% 450
2016
Q1
$11.9M Sell
86,997
-1,716
-2% -$236K 0.04% 460
2015
Q4
$13M Buy
88,713
+18,416
+26% +$2.53M 0.05% 428
2015
Q3
$9.49M Buy
70,297
+4,418
+7% +$641K 0.04% 499
2015
Q2
$10.7M Sell
65,879
-1,989
-3% -$275K 0.04% 493
2015
Q1
$8.79M Buy
67,868
+1,990
+3% +$231K 0.04% 500
2014
Q4
$6.78M Buy
65,878
+30,137
+84% +$2.97M 0.03% 546
2014
Q3
$3.24M Sell
35,741
-33,368
-48% -$3.12M 0.02% 837
2014
Q2
$6.36M Sell
69,109
-13,300
-16% -$1.14M 0.04% 525
2014
Q1
$6.9M Sell
82,409
-48,433
-37% -$3.99M 0.05% 455
2013
Q4
$11.4M Sell
130,842
-286
-0.2% -$23.4K 0.09% 262
2013
Q3
$10.1M Buy
131,128
+1,280
+1% +$99.9K 0.09% 259
2013
Q2
$9.41M Buy
+129,848
New +$8.75M 0.09% 251

Other funds holding CI

Raymond James & Associates's CI Position: Q3 2024 in Review

Raymond James & Associates increased its Cigna (CI) stake by 43% in Q3 2024, buying an estimated $88.7M and bringing the position to 860,050 shares worth $298M. The position accounts for 0.18% of the portfolio, ranked #99.

Raymond James & Associates first reported a position in CI in Q2 2013 and has held it in 46 quarters since. 1,703 funds tracked by Wall St. Rank hold CI as of Q3 2024.

  • Raymond James & Associates held 860,050 shares of Cigna worth $298M as of Q3 2024.
  • Raymond James & Associates bought 257,711 Cigna shares in Q3 2024, an estimated $88.7M.
  • Cigna made up 0.18% of Raymond James & Associates's portfolio in Q3 2024, its #99 holding.
  • Raymond James & Associates first reported a position in Cigna in Q2 2013 and has held it in 46 quarters since.
  • 1,703 funds tracked by Wall St. Rank held Cigna as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.